Semaglutide

Semaglutide is a synthetic GLP-1 receptor agonist supplied as a lyophilized powder for controlled laboratory research. Verified by High-Performance Liquid Chromatography (HPLC) to a purity of ≥99%, it is formulated to meet the consistency and reproducibility demands of professional research environments. Its strong binding affinity for the GLP-1 receptor makes it a well-established model compound in metabolic and endocrine research.

Research background

Semaglutide has been extensively studied in the context of GLP-1 receptor signalling, with the literature referencing its role as a model compound for investigating peptide–receptor interactions and downstream intracellular cascades. It has been investigated in relation to glucose regulation, energy homeostasis, and hormonal signalling pathways. Research groups have also referenced semaglutide in studies examining metabolic regulation and endocrine function, making it a relevant reference compound across a range of in-vitro experimental frameworks focused on these areas.

Reconstitution & handling

Semaglutide is supplied as a lyophilised powder and should be reconstituted with an appropriate volume of bacteriostatic water (BAC water) prior to use. To dissolve the powder, gently swirl the vial — do not shake, as vigorous agitation may compromise peptide integrity. Once reconstituted, handle the solution with care and keep it cold at all times. Use sterile technique throughout to maintain sample quality.

Storage & stability

The lyophilised powder should be stored refrigerated and protected from light and moisture. Once reconstituted, the solution should be kept refrigerated and used promptly within a short time window to preserve activity and prevent degradation. Avoid repeated freeze-thaw cycles.

A batch-specific Certificate of Analysis (CoA), confirming purity and identity, accompanies every order.